vs

Side-by-side financial comparison of Orange County Bancorp, Inc. (OBT) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $17.6M, roughly 1.9× AVITA Medical, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -66.0%, a 103.6% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -4.3%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 14.3%).

Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

OBT vs RCEL — Head-to-Head

Bigger by revenue
OBT
OBT
1.9× larger
OBT
$33.0M
$17.6M
RCEL
Growing faster (revenue YoY)
OBT
OBT
+24.9% gap
OBT
20.6%
-4.3%
RCEL
Higher net margin
OBT
OBT
103.6% more per $
OBT
37.6%
-66.0%
RCEL
More free cash flow
OBT
OBT
$47.4M more FCF
OBT
$41.3M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
14.3%
OBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OBT
OBT
RCEL
RCEL
Revenue
$33.0M
$17.6M
Net Profit
$12.4M
$-11.6M
Gross Margin
81.2%
Operating Margin
41.4%
-59.1%
Net Margin
37.6%
-66.0%
Revenue YoY
20.6%
-4.3%
Net Profit YoY
73.5%
-0.3%
EPS (diluted)
$0.94
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBT
OBT
RCEL
RCEL
Q4 25
$33.0M
$17.6M
Q3 25
$33.7M
$17.1M
Q2 25
$32.5M
$18.4M
Q1 25
$28.0M
$18.5M
Q4 24
$27.4M
$18.4M
Q3 24
$27.1M
$19.5M
Q2 24
$27.9M
$15.2M
Q1 24
$25.3M
$11.1M
Net Profit
OBT
OBT
RCEL
RCEL
Q4 25
$12.4M
$-11.6M
Q3 25
$10.0M
$-13.2M
Q2 25
$10.5M
$-9.9M
Q1 25
$8.7M
$-13.9M
Q4 24
$7.2M
$-11.6M
Q3 24
$3.2M
$-16.2M
Q2 24
$8.2M
$-15.4M
Q1 24
$9.3M
$-18.7M
Gross Margin
OBT
OBT
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
OBT
OBT
RCEL
RCEL
Q4 25
41.4%
-59.1%
Q3 25
38.6%
-53.6%
Q2 25
41.9%
-60.5%
Q1 25
40.3%
-63.9%
Q4 24
32.8%
-54.1%
Q3 24
14.8%
-70.6%
Q2 24
36.6%
-102.8%
Q1 24
45.9%
-155.0%
Net Margin
OBT
OBT
RCEL
RCEL
Q4 25
37.6%
-66.0%
Q3 25
29.7%
-77.3%
Q2 25
32.2%
-53.9%
Q1 25
31.1%
-74.9%
Q4 24
26.2%
-63.0%
Q3 24
11.8%
-82.9%
Q2 24
29.4%
-101.3%
Q1 24
36.7%
-168.0%
EPS (diluted)
OBT
OBT
RCEL
RCEL
Q4 25
$0.94
$-0.37
Q3 25
$0.75
$-0.46
Q2 25
$0.87
$-0.38
Q1 25
$0.77
$-0.53
Q4 24
$0.64
$-0.44
Q3 24
$0.28
$-0.62
Q2 24
$0.73
$-0.60
Q1 24
$0.82
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBT
OBT
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$284.4M
$-16.6M
Total Assets
$2.7B
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBT
OBT
RCEL
RCEL
Q4 25
$18.2M
Q3 25
$23.3M
Q2 25
$15.7M
Q1 25
$25.8M
Q4 24
$35.9M
Q3 24
$44.4M
Q2 24
$54.1M
Q1 24
$68.2M
Stockholders' Equity
OBT
OBT
RCEL
RCEL
Q4 25
$284.4M
$-16.6M
Q3 25
$270.1M
$-6.7M
Q2 25
$252.6M
$-12.9M
Q1 25
$201.3M
$-4.6M
Q4 24
$185.5M
$4.5M
Q3 24
$193.1M
$12.2M
Q2 24
$177.5M
$23.9M
Q1 24
$168.7M
$32.6M
Total Assets
OBT
OBT
RCEL
RCEL
Q4 25
$2.7B
$56.4M
Q3 25
$2.6B
$63.7M
Q2 25
$2.6B
$58.1M
Q1 25
$2.6B
$69.6M
Q4 24
$2.5B
$79.7M
Q3 24
$2.5B
$81.1M
Q2 24
$2.5B
$87.8M
Q1 24
$2.5B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBT
OBT
RCEL
RCEL
Operating Cash FlowLast quarter
$43.8M
$-5.4M
Free Cash FlowOCF − Capex
$41.3M
$-6.1M
FCF MarginFCF / Revenue
125.1%
-34.7%
Capex IntensityCapex / Revenue
7.6%
3.8%
Cash ConversionOCF / Net Profit
3.53×
TTM Free Cash FlowTrailing 4 quarters
$69.6M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBT
OBT
RCEL
RCEL
Q4 25
$43.8M
$-5.4M
Q3 25
$30.2M
$-5.2M
Q2 25
$-5.0M
$-10.2M
Q1 25
$4.8M
$-10.3M
Q4 24
$34.6M
$-8.1M
Q3 24
$10.2M
$-7.2M
Q2 24
$9.3M
$-12.8M
Q1 24
$2.3M
$-20.9M
Free Cash Flow
OBT
OBT
RCEL
RCEL
Q4 25
$41.3M
$-6.1M
Q3 25
$29.6M
$-6.2M
Q2 25
$-5.7M
$-10.8M
Q1 25
$4.3M
$-10.5M
Q4 24
$32.9M
$-9.7M
Q3 24
$10.0M
$-11.0M
Q2 24
$9.2M
$-15.4M
Q1 24
$2.0M
$-22.0M
FCF Margin
OBT
OBT
RCEL
RCEL
Q4 25
125.1%
-34.7%
Q3 25
87.8%
-36.1%
Q2 25
-17.5%
-58.4%
Q1 25
15.5%
-56.9%
Q4 24
120.0%
-52.7%
Q3 24
36.7%
-56.1%
Q2 24
32.8%
-101.6%
Q1 24
7.9%
-198.2%
Capex Intensity
OBT
OBT
RCEL
RCEL
Q4 25
7.6%
3.8%
Q3 25
1.8%
5.5%
Q2 25
2.3%
2.8%
Q1 25
1.8%
1.2%
Q4 24
6.3%
8.8%
Q3 24
1.1%
19.2%
Q2 24
0.4%
17.5%
Q1 24
1.0%
10.3%
Cash Conversion
OBT
OBT
RCEL
RCEL
Q4 25
3.53×
Q3 25
3.01×
Q2 25
-0.47×
Q1 25
0.56×
Q4 24
4.83×
Q3 24
3.19×
Q2 24
1.13×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons